Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.

Aapro M, Bernard-Marty C, Brain EG, Batist G, Erdkamp F, Krzemieniecki K, Leonard R, Lluch A, Monfardini S, Ryberg M, Soubeyran P, Wedding U.

Ann Oncol. 2011 Feb;22(2):257-67. doi: 10.1093/annonc/mdq609. Epub 2010 Oct 18. Review.

PMID:
20956616
2.

Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.

Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A.

Health Technol Assess. 2007 Jul;11(27):iii, ix-x, 1-84. Review.

3.

Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.

Iarussi D, Indolfi P, Casale F, Martino V, Di Tullio MT, Calabrò R.

Paediatr Drugs. 2005;7(2):67-76. Review.

PMID:
15871628
4.

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials.

Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A.

BMC Cancer. 2010 Jun 29;10:337. doi: 10.1186/1471-2407-10-337. Review.

5.

Cardiac complications in childhood cancer survivors treated with anthracyclines.

Franco VI, Lipshultz SE.

Cardiol Young. 2015 Aug;25 Suppl 2:107-16. doi: 10.1017/S1047951115000906. Review.

PMID:
26377717
6.

Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.

Gavila J, Seguí MÁ, Calvo L, López T, Alonso JJ, Farto M, Sánchez-de la Rosa R.

Clin Transl Oncol. 2017 Jan;19(1):91-104. doi: 10.1007/s12094-016-1508-y. Epub 2016 Apr 21.

7.

Exposure to anthracyclines during childhood causes cardiac injury.

Lipshultz SE.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. Review.

PMID:
16781284
8.

Pathogenesis of cardiotoxicity induced by anthracyclines.

Elliott P.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S2-7. Review.

PMID:
16781283
9.

Anthracycline cardiotoxicity.

Menna P, Paz OG, Chello M, Covino E, Salvatorelli E, Minotti G.

Expert Opin Drug Saf. 2012 May;11 Suppl 1:S21-36. doi: 10.1517/14740338.2011.589834. Epub 2011 Jun 2. Review.

PMID:
21635149
11.

Anthracycline-associated cardiotoxicity in survivors of childhood cancer.

Trachtenberg BH, Landy DC, Franco VI, Henkel JM, Pearson EJ, Miller TL, Lipshultz SE.

Pediatr Cardiol. 2011 Mar;32(3):342-53. doi: 10.1007/s00246-010-9878-3. Epub 2011 Jan 9.

PMID:
21221562
12.

Anthracycline-related cardiotoxicity in childhood cancer survivors.

Lipshultz SE, Karnik R, Sambatakos P, Franco VI, Ross SW, Miller TL.

Curr Opin Cardiol. 2014 Jan;29(1):103-12. doi: 10.1097/HCO.0000000000000034. Review.

PMID:
24284979
13.

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.

Barrett-Lee PJ, Dixon JM, Farrell C, Jones A, Leonard R, Murray N, Palmieri C, Plummer CJ, Stanley A, Verrill MW.

Ann Oncol. 2009 May;20(5):816-27. doi: 10.1093/annonc/mdn728. Epub 2009 Jan 19. Review.

PMID:
19153118
14.

Anthracycline-induced cardiotoxicity in adult hematologic malignancies.

Johnson SA.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S22-7. Review.

PMID:
16781286
15.

Dexrazoxane : a review of its use for cardioprotection during anthracycline chemotherapy.

Cvetković RS, Scott LJ.

Drugs. 2005;65(7):1005-24. Review.

PMID:
15892593
16.

Epidemiology of anthracycline cardiotoxicity in children and adults.

Grenier MA, Lipshultz SE.

Semin Oncol. 1998 Aug;25(4 Suppl 10):72-85. Review.

PMID:
9768828
17.

Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.

Jensen BV.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S15-21. Review.

PMID:
16781285
18.

Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.

van Dalen EC, van der Pal HJ, Kremer LC.

Cochrane Database Syst Rev. 2016 Mar 3;3:CD005008. doi: 10.1002/14651858.CD005008.pub4. Review.

PMID:
26938118
19.

Anthracycline cardiotoxicity after breast cancer treatment.

Hershman DL, Shao T.

Oncology (Williston Park). 2009 Mar;23(3):227-34. Review.

20.

Cardiotoxicity and cardioprotection in childhood cancer.

Lipshultz SE, Sambatakos P, Maguire M, Karnik R, Ross SW, Franco VI, Miller TL.

Acta Haematol. 2014;132(3-4):391-9. doi: 10.1159/000360238. Epub 2014 Sep 10. Review.

PMID:
25228565

Supplemental Content

Support Center